Literature DB >> 2054797

From gene to carcinogen: a rapidly evolving field in molecular epidemiology.

P A Jones1, J D Buckley, B E Henderson, R K Ross, M C Pike.   

Abstract

Chemical and physical carcinogens leave footprints of their activities on DNA because of the patterns of base changes they induce. Additionally, the conversion of 5-methylcytosine to thymine in CpG sequences leads to a characteristic mutation which can be used to estimate the contribution of endogenous processes to human mutations. Knowledge of the pattern mutations found in genes commonly mutated in human cancer, such as the p53 tumor suppressor gene, allows for predictions to be made on the likelihood of an exogenous DNA-damaging agent being involved. Working from gene to carcinogen is likely to have a profound impact on our understanding of the origins of human cancer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2054797

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

1.  Evolution of gene sequence in response to chromosomal location.

Authors:  Carlos Díaz-Castillo; Kent G Golic
Journal:  Genetics       Date:  2007-09       Impact factor: 4.562

2.  Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation.

Authors:  M Hollstein; B Shomer; M Greenblatt; T Soussi; E Hovig; R Montesano; C C Harris
Journal:  Nucleic Acids Res       Date:  1996-01-01       Impact factor: 16.971

3.  An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma.

Authors:  Y Sun; G Hegamyer; Y J Cheng; A Hildesheim; J Y Chen; I H Chen; Y Cao; K T Yao; N H Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

4.  Tobacco smoke: chemical carcinogenesis and genetic lesions.

Authors:  J L Cook
Journal:  Ochsner J       Date:  1999-07

5.  Novel pattern of P53 mutation in breast cancers from Austrian women.

Authors:  A Hartmann; G Rosanelli; H Blaszyk; J M Cunningham; R M McGovern; J J Schroeder; D J Schaid; J S Kovach; S S Sommer
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

6.  Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene.

Authors:  Zhipei Liu; Manfred Hergenhahn; Heinz H Schmeiser; Gerald N Wogan; Amanda Hong; Monica Hollstein
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-19       Impact factor: 11.205

Review 7.  Superficial bladder cancer.

Authors:  R R Hall
Journal:  BMJ       Date:  1994-04-02

Review 8.  Genetics of primary brain tumors: a review.

Authors:  M Bondy; J Wiencke; M Wrensch; A P Kyritsis
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

9.  Database of p53 gene somatic mutations in human tumors and cell lines.

Authors:  M Hollstein; K Rice; M S Greenblatt; T Soussi; R Fuchs; T Sørlie; E Hovig; B Smith-Sørensen; R Montesano; C C Harris
Journal:  Nucleic Acids Res       Date:  1994-09       Impact factor: 16.971

Review 10.  Modulation of oncogene and tumor-suppressor gene expression: a novel strategy for cancer prevention and treatment.

Authors:  J A Roth
Journal:  Ann Surg Oncol       Date:  1994-01       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.